These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8490934)

  • 21. Myocardial function structure and collagen in the spontaneously hypertensive rat: progression from compensated hypertrophy to haemodynamic impairment.
    Bing OH; Sen S; Conrad CH; Brooks WW
    Eur Heart J; 1984 Dec; 5 Suppl F():43-52. PubMed ID: 6241902
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of modern components of the mechanism of cardiac hypertrophy.
    Meerson FZ
    Circ Res; 1974 Aug; 35(2):suppl II:58-63. PubMed ID: 4276489
    [No Abstract]   [Full Text] [Related]  

  • 23. [On some aspects of cardiac dynamics in myocardial diseases in the infantile age].
    Garello L; Ribaldone D; Corazza G
    Minerva Cardioangiol; 1971 Aug; 19(8):424-9. PubMed ID: 4254321
    [No Abstract]   [Full Text] [Related]  

  • 24. [Haemodynamics and contractility reserve in myocardial disease].
    Roskamm H; Blümchen G; Fiebig H; Schnellbacher K; Wink K; Pabst K; Schollmeyer P; Lösel E; Weidemann H; Reindell H
    Dtsch Med Wochenschr; 1972 Nov; 97(44):1681-7. PubMed ID: 4264353
    [No Abstract]   [Full Text] [Related]  

  • 25. [Functional and metabolic shifts in cardiomyopathies].
    Popovich MI; Mukharliamov NM; Zatushevskiĭ IF; Severin VV; Saks VA
    Vestn Akad Med Nauk SSSR; 1984; (2):33-6. PubMed ID: 6711106
    [No Abstract]   [Full Text] [Related]  

  • 26. Is the inotropic effect of digoxin maintained? An illustrative case report.
    Griffiths BE; Dalal JJ; Dowdle R; Henderson AH
    Eur Heart J; 1982 Jun; 3(3):282-5. PubMed ID: 6213413
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular mechanisms of alterations in myocardial contractile function in experimental cardiomyopathies.
    Kapelko VI; Veksler VI; Popovich MI
    Biomed Sci; 1990 Jan; 1(1):77-83. PubMed ID: 2130921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical studies concerning etiology of hypertrophy, heart failure, and cardiomyopathy.
    Schwartz A
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():501-2. PubMed ID: 4283354
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular mechanisms of inherited cardiomyopathies.
    Fatkin D; Graham RM
    Physiol Rev; 2002 Oct; 82(4):945-80. PubMed ID: 12270949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some biochemical lesions in myocardial disease.
    Sordahl LA
    Tex Rep Biol Med; 1979; 38():121-35. PubMed ID: 161081
    [No Abstract]   [Full Text] [Related]  

  • 32. Physiology of idiopathic cardiomyopathies.
    Schlant RC
    Cardiovasc Clin; 1972; 4(1):61-76. PubMed ID: 4265685
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contractility of the left ventricle in aortic valve stenosis; significance of myocardial hypertrophy].
    Hess OM; Brunner HH; Goebel NH; Krayenbühl HP
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():152-5. PubMed ID: 1007558
    [No Abstract]   [Full Text] [Related]  

  • 34. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
    Kennedy DJ; Vetteth S; Periyasamy SM; Kanj M; Fedorova L; Khouri S; Kahaleh MB; Xie Z; Malhotra D; Kolodkin NI; Lakatta EG; Fedorova OV; Bagrov AY; Shapiro JI
    Hypertension; 2006 Mar; 47(3):488-95. PubMed ID: 16446397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and hemodynamic aspects of myocardial diseases (author's transl)].
    Wink K; Brett W; Hagemann G; Barmeyer J; Reindell H
    MMW Munch Med Wochenschr; 1976 Jun; 118(23):759-62. PubMed ID: 132610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular hypertrophy in clinical practice: cardiomyopathies.
    Kuhn H
    Eur Heart J; 1982 Apr; 3 Suppl A():187-92. PubMed ID: 6210545
    [No Abstract]   [Full Text] [Related]  

  • 37. Dexamethasone-induced histopathology of neonatal rat myocardium.
    Sicard RE; Werner JC
    In Vivo; 1994; 8(3):353-8. PubMed ID: 7803717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electromyography studies in patients with hypertrophic obstructive cardiomyopathies].
    Meerschwam IS; Hootsmans WJ
    Ned Tijdschr Geneeskd; 1970 Jan; 114(3):131-5. PubMed ID: 4243455
    [No Abstract]   [Full Text] [Related]  

  • 39. Heterogeneity of contractile function in cardiac hypertrophy.
    Skelton CL; Sonnenblick EH
    Circ Res; 1974 Aug; 35(2):suppl II:83-96. PubMed ID: 4276492
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperthyroid cardiomyopathy: disorders in the creatine transport system and increased sensitivity to ischemic damage].
    Seppet EK; Adoian AI; Kallikorm AP; Chernousova GB; Liulina NV
    Vestn Akad Med Nauk SSSR; 1984; (10):48-56. PubMed ID: 6506854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.